US4851424A
(en)
*
|
1986-06-06 |
1989-07-25 |
Ciba-Geigy Corporation |
1-Phenyl-lower alkyl-imidazole 4- or 5-carboxamide compounds which are useful in the treatment of epilepsy
|
US5138069A
(en)
*
|
1986-07-11 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking imidazoles
|
US4851423A
(en)
*
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
IL86134A
(en)
*
|
1987-05-02 |
1993-06-10 |
Basf Ag |
N-substituted azoles, their manufacture and their use as pesticides and compositions containing them
|
US4820843A
(en)
*
|
1987-05-22 |
1989-04-11 |
E. I. Du Pont De Nemours And Company |
Tetrazole intermediates to antihypertensive compounds
|
US5315013A
(en)
*
|
1988-01-07 |
1994-05-24 |
E. I. Du Pont De Nemours And Company |
Substituted pyrazole angiotensin II antagonists
|
US5015651A
(en)
*
|
1988-01-07 |
1991-05-14 |
E. I. Du Pont De Nemours And Company |
Treatment of hypertension with 1,2,4-angiotensin II antagonists
|
US5081127A
(en)
*
|
1988-01-07 |
1992-01-14 |
E. I. Du Pont De Nemours And Company |
Substituted 1,2,3-triazole angiotensin II antagonists
|
US5210079A
(en)
*
|
1988-01-07 |
1993-05-11 |
E. I. Du Pont De Nemours And Company |
Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
|
CA1338238C
(en)
*
|
1988-01-07 |
1996-04-09 |
David John Carini |
Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
|
US5189048A
(en)
*
|
1988-01-07 |
1993-02-23 |
E. I. Du Pont De Nemours And Company |
Substituted 1,2,3 triazole angiotensin II antagonists
|
US5354867A
(en)
*
|
1988-12-06 |
1994-10-11 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking imidazoles
|
US4916129A
(en)
*
|
1989-01-19 |
1990-04-10 |
E. I. Du Pont De Nemours And Company |
Combination β-blocking/angiotensin II blocking antihypertensives
|
DE3928177A1
(de)
*
|
1989-04-08 |
1991-02-28 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
EP0400835A1
(en)
*
|
1989-05-15 |
1990-12-05 |
Merck & Co. Inc. |
Substituted benzimidazoles as angiotensin II antagonists
|
GB8911854D0
(en)
*
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
IL94390A
(en)
*
|
1989-05-30 |
1996-03-31 |
Merck & Co Inc |
The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
|
US5157026A
(en)
*
|
1989-05-30 |
1992-10-20 |
Merck & Co., Inc. |
Oxo-purines as angiotensin II antagonists
|
US5332744A
(en)
*
|
1989-05-30 |
1994-07-26 |
Merck & Co., Inc. |
Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
|
US5064825A
(en)
*
|
1989-06-01 |
1991-11-12 |
Merck & Co., Inc. |
Angiotensin ii antagonists
|
US5312828A
(en)
*
|
1989-06-14 |
1994-05-17 |
Finkelstein Joseph A |
Substituted imidazoles having angiotensin II receptor blocking activity
|
DK0955294T3
(da)
*
|
1989-06-14 |
2004-02-02 |
Smithkline Beecham Corp |
Imidazolylalkensyre
|
US5418250A
(en)
*
|
1989-06-14 |
1995-05-23 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
|
CA2018443A1
(en)
*
|
1989-06-14 |
1990-12-14 |
Joseph A. Finkelstein |
Imidazolyl-alkenoic acids
|
US5185351A
(en)
*
|
1989-06-14 |
1993-02-09 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
|
WO1991000281A2
(en)
|
1989-06-30 |
1991-01-10 |
E.I. Du Pont De Nemours And Company |
Fused-ring aryl substituted imidazoles
|
ATE134368T1
(de)
*
|
1989-06-30 |
1996-03-15 |
Du Pont |
Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
|
CA2020073A1
(en)
*
|
1989-07-03 |
1991-01-04 |
Eric E. Allen |
Substituted quinazolinones as angiotensin ii antagonists
|
US5240928A
(en)
*
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
EP0407342A3
(en)
*
|
1989-07-06 |
1991-07-10 |
Ciba-Geigy Ag |
Pyrimidine derivatives
|
EP0409332A3
(en)
*
|
1989-07-19 |
1991-08-07 |
Merck & Co. Inc. |
Substituted triazoles as angiotensin ii antagonists
|
EP0411507B1
(en)
*
|
1989-08-02 |
1994-10-26 |
Takeda Chemical Industries, Ltd. |
Pyrazole derivatives, their production and use
|
PT94960A
(pt)
*
|
1989-08-11 |
1991-04-18 |
Ici Plc |
Processo para a preparacao de derivados de quinolina e de composicoes farmaceuticas que as contem
|
US5100897A
(en)
*
|
1989-08-28 |
1992-03-31 |
Merck & Co., Inc. |
Substituted pyrimidinones as angiotensin ii antagonists
|
IE70593B1
(en)
*
|
1989-09-29 |
1996-12-11 |
Eisai Co Ltd |
Biphenylmethane derivative the use of it and pharmacological compositions containing same
|
US5298518A
(en)
*
|
1989-09-29 |
1994-03-29 |
Eisai Co., Ltd. |
Biphenylmethane derivative and pharmacological use
|
EP0424317A3
(en)
*
|
1989-10-19 |
1991-09-25 |
Ciba-Geigy Ag |
Pyrimidines
|
US5250554A
(en)
*
|
1989-10-24 |
1993-10-05 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives useful as angiotensin II inhibitors
|
IL95975A
(en)
*
|
1989-10-24 |
1997-06-10 |
Takeda Chemical Industries Ltd |
N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
|
CA2027937A1
(en)
*
|
1989-10-25 |
1991-04-26 |
Richard M. Keenan |
Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles
|
US5177096A
(en)
*
|
1989-10-25 |
1993-01-05 |
Smithkline Beecham Corporation |
Substituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical methods of use thereof
|
IL96019A0
(en)
*
|
1989-10-31 |
1991-07-18 |
Fujisawa Pharmaceutical Co |
Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
|
US5248689A
(en)
*
|
1989-11-06 |
1993-09-28 |
Smithkline Beecham Corporation |
Substituted N-(imidazolyl)alkyl alanine derivatives
|
CA2028925A1
(en)
*
|
1989-11-06 |
1991-05-07 |
Gerald R. Girard |
Substituted n-(imidazolyl)alkyl alanine derivatives
|
PT95899A
(pt)
*
|
1989-11-17 |
1991-09-13 |
Glaxo Group Ltd |
Processo para a preparacao de derivados indole
|
IE903911A1
(en)
*
|
1989-11-20 |
1991-05-22 |
Ici Plc |
Diazine derivatives
|
US5073566A
(en)
*
|
1989-11-30 |
1991-12-17 |
Eli Lilly And Company |
Angiotensin ii antagonist 1,3-imidazoles and use thereas
|
US5104891A
(en)
*
|
1989-12-11 |
1992-04-14 |
G. D. Searle & Co. |
Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension
|
EP0434038A1
(en)
*
|
1989-12-22 |
1991-06-26 |
Takeda Chemical Industries, Ltd. |
Fused imidazole derivatives, their production and use
|
US5234917A
(en)
*
|
1989-12-29 |
1993-08-10 |
Finkelstein Joseph A |
Substituted 5-(alkyl)carboxamide imidazoles
|
ZA9010460B
(en)
*
|
1989-12-29 |
1992-11-25 |
Univ Technologies Int |
Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
|
US5449682A
(en)
*
|
1990-02-13 |
1995-09-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted benzyl element
|
DE69129998T2
(de)
*
|
1990-02-15 |
1998-12-24 |
Takeda Chemical Industries, Ltd., Osaka |
Pyrimidindionderivate, deren Herstellung und Verwendung
|
DE59107440D1
(de)
*
|
1990-02-19 |
1996-04-04 |
Ciba Geigy Ag |
Acylverbindungen
|
KR910021381A
(ko)
*
|
1990-02-20 |
1991-12-20 |
모리 히데오 |
4-3급 부틸이미다졸 유도체, 및 이의 제조방법 및 용도
|
US5284661A
(en)
*
|
1990-02-22 |
1994-02-08 |
Takeda Chemical Industries, Ltd. |
Fused thiophene derivatives, their production and use
|
CA2037630C
(en)
*
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
FR2665702B1
(fr)
*
|
1990-08-08 |
1994-02-25 |
Sanofi |
Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
US5270317A
(en)
*
|
1990-03-20 |
1993-12-14 |
Elf Sanofi |
N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
|
PT97078B
(pt)
*
|
1990-03-20 |
1997-07-31 |
Sanofi Sa |
Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem
|
FR2659967B1
(fr)
*
|
1990-03-20 |
1992-07-24 |
Sanofi Sa |
Derives d'imidazolinone n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
US5166206A
(en)
*
|
1990-03-30 |
1992-11-24 |
Merck & Co., Inc. |
Substituted pyrimidines, pyrimidinones and pyridopyrimidines
|
DE4010797A1
(de)
*
|
1990-04-04 |
1991-10-10 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
|
EP0453210A3
(en)
*
|
1990-04-19 |
1993-01-13 |
Imperial Chemical Industries Plc |
Pyridine derivatives
|
US5198439A
(en)
*
|
1990-04-19 |
1993-03-30 |
Imperial Chemical Industries Plc |
Angiotension II antagonizing pyridine derivatives
|
US5196444A
(en)
*
|
1990-04-27 |
1993-03-23 |
Takeda Chemical Industries, Ltd. |
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
|
US5703110A
(en)
*
|
1990-04-27 |
1997-12-30 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
ZA912983B
(en)
|
1990-04-27 |
1992-01-29 |
Takeda Chemical Industries Ltd |
Benzimidazole derivatives,their production and use
|
US6004989A
(en)
|
1990-04-27 |
1999-12-21 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
US5098920A
(en)
*
|
1990-05-04 |
1992-03-24 |
G. D. Searle & Co. |
1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
|
US5821232A
(en)
*
|
1990-05-11 |
1998-10-13 |
Pfizer Inc. |
Synergistic therapeutic compositions and methods
|
JPH0729938B2
(ja)
|
1990-05-11 |
1995-04-05 |
フアイザー・インコーポレイテツド |
相乗的治療用組成物及び方法
|
US5045540A
(en)
*
|
1990-05-25 |
1991-09-03 |
Warner-Lambert Co. |
Amino acid derivatives with angiotensin II antagonist properties
|
FR2674523A1
(fr)
*
|
1991-03-28 |
1992-10-02 |
Roussel Uclaf |
Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
AU7820091A
(en)
*
|
1990-06-08 |
1991-12-12 |
Roussel-Uclaf |
New benzimidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
|
EP0461040A1
(fr)
|
1990-06-08 |
1991-12-11 |
Roussel Uclaf |
Dérivés de l'imidazole, leur procédé de préparation, les intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
|
FR2663028B1
(fr)
*
|
1990-06-08 |
1994-10-14 |
Roussel Uclaf |
Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
FR2670489B1
(fr)
*
|
1990-12-18 |
1994-10-14 |
Roussel Uclaf |
Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
WO1991019715A1
(en)
*
|
1990-06-15 |
1991-12-26 |
G.D. Searle & Co. |
1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
|
NZ238688A
(en)
*
|
1990-06-28 |
1992-05-26 |
Smithkline Beecham Corp |
Substituted histidines: pharmaceutical compositions, preparation and uses thereof
|
CA2036147A1
(en)
*
|
1990-06-29 |
1991-12-30 |
Hiroki Tomioka |
A 1-pyridylimidazole derivative and its production and use
|
FR2675503B1
(fr)
*
|
1991-04-19 |
1994-02-18 |
Roussel Uclaf |
Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
FR2664271B1
(fr)
*
|
1990-07-05 |
1994-02-18 |
Roussel Uclaf |
Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
IL98319A
(en)
*
|
1990-07-05 |
1997-04-15 |
Roussel Uclaf |
Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
|
CA2044806A1
(en)
*
|
1990-07-18 |
1992-01-19 |
Roland Jaunin |
Purine derivatives
|
DE4023215A1
(de)
*
|
1990-07-21 |
1992-01-23 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
|
NZ239161A
(en)
*
|
1990-07-31 |
1994-01-26 |
Smithkline Beecham Corp |
Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
|
GB9017482D0
(en)
*
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Manufacturing process
|
GB9017480D0
(en)
*
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Chemical process
|
AU8534291A
(en)
*
|
1990-08-10 |
1992-03-02 |
G.D. Searle & Co. |
Renal-selective angiotensin ii antagonists for treatment of hypertension
|
US5089626A
(en)
*
|
1990-08-23 |
1992-02-18 |
Merck & Co., Inc. |
Process for preparing an angiotensin II antagonist
|
US5217985A
(en)
*
|
1990-08-28 |
1993-06-08 |
G. D. Searle & Co. |
Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
|
US5140036A
(en)
*
|
1990-09-19 |
1992-08-18 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5229406A
(en)
*
|
1990-09-19 |
1993-07-20 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5091390A
(en)
*
|
1990-09-20 |
1992-02-25 |
E. I. Du Pont De Nemours And Company |
Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4,5-)-pyridines and analogs
|
EP0481614A1
(en)
*
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
US5126342A
(en)
*
|
1990-10-01 |
1992-06-30 |
Merck & Co., Inc. |
Imidazole angiotensin ii antagonists incorporating acidic functional groups
|
AU9024591A
(en)
*
|
1990-10-25 |
1992-05-26 |
G.D. Searle & Co. |
Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders
|
AU636066B2
(en)
*
|
1990-10-30 |
1993-04-08 |
Takeda Chemical Industries Ltd. |
Thienoimidazole derivatives, their production and use
|
US5238952A
(en)
*
|
1990-10-31 |
1993-08-24 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
US5087634A
(en)
*
|
1990-10-31 |
1992-02-11 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
GB9025123D0
(en)
*
|
1990-11-19 |
1991-01-02 |
Ici Plc |
Nitrogen compounds
|
WO1992010189A1
(en)
*
|
1990-12-14 |
1992-06-25 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids
|
US5175180A
(en)
*
|
1990-12-20 |
1992-12-29 |
G. D. Searle & Co. |
N-substituted n-(alpha-triazolyl-toluyl)pyrrole compounds and use for treatment of circulatory disorders
|
CA2058198A1
(en)
*
|
1991-01-04 |
1992-07-05 |
Adalbert Wagner |
Azole derivatives, process for their preparation, and their use
|
IE914572A1
(en)
*
|
1991-01-17 |
1992-07-29 |
Zeneca Ltd |
Chemical process
|
IE914573A1
(en)
*
|
1991-01-17 |
1992-07-29 |
Ici Plc |
Boron compounds
|
AT395853B
(de)
*
|
1991-01-31 |
1993-03-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
GB9102803D0
(en)
*
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Pyridine compounds
|
IE920175A1
(en)
*
|
1991-02-11 |
1992-08-12 |
Zeneca Ltd |
Nitrogen heterocycles
|
FR2672892B1
(fr)
*
|
1991-02-20 |
1994-01-14 |
Synthelabo |
Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.
|
US5472967A
(en)
*
|
1991-02-20 |
1995-12-05 |
Synthelabo |
4-pyrimidinone derivatives their preparation and their application in therapy
|
US5616599A
(en)
*
|
1991-02-21 |
1997-04-01 |
Sankyo Company, Limited |
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
|
IS1756B
(is)
|
1991-02-21 |
2000-12-28 |
Sankyo Company Limited |
Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
|
US5187271A
(en)
*
|
1991-02-28 |
1993-02-16 |
G. D. Searle & Co. |
N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
|
US6008368A
(en)
*
|
1993-04-28 |
1999-12-28 |
G. D. Searle & Co. |
Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists
|
EP0502575A1
(en)
*
|
1991-03-06 |
1992-09-09 |
Merck & Co. Inc. |
Substituted 1-(2H)-isoquinolinones
|
US5202328A
(en)
*
|
1991-03-06 |
1993-04-13 |
Merck & Co., Inc. |
Substituted fused pyrimidinones
|
US5385894A
(en)
*
|
1991-03-06 |
1995-01-31 |
Merck & Co., Inc. |
Disubstituted 6-aminoquinazolinones
|
US5191086A
(en)
*
|
1991-03-19 |
1993-03-02 |
E.R. Squibb & Sons, Inc. |
Imidazole and benzimidazole derivatives
|
EP0505098A1
(en)
*
|
1991-03-19 |
1992-09-23 |
Merck & Co. Inc. |
Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists
|
US5236928A
(en)
*
|
1991-03-19 |
1993-08-17 |
Merck & Co., Inc. |
Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists
|
US5206235A
(en)
*
|
1991-03-20 |
1993-04-27 |
Merck & Co., Inc. |
Benzo-fused lactams that promote the release of growth hormone
|
US5196537A
(en)
*
|
1991-03-21 |
1993-03-23 |
G. D. Searle & Co. |
5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5187179A
(en)
*
|
1991-03-22 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole
|
US5128327A
(en)
*
|
1991-03-25 |
1992-07-07 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
|
US5177074A
(en)
*
|
1991-03-26 |
1993-01-05 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
US5164403A
(en)
*
|
1991-04-05 |
1992-11-17 |
G. D. Searle & Co. |
N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
|
US5155117A
(en)
*
|
1991-04-12 |
1992-10-13 |
G. D. Searle & Co. |
1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
|
TW274551B
(xx)
*
|
1991-04-16 |
1996-04-21 |
Takeda Pharm Industry Co Ltd |
|
US5190942A
(en)
*
|
1991-04-22 |
1993-03-02 |
E. R. Squibb & Sons, Inc. |
Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives
|
SK117793A3
(en)
*
|
1991-04-29 |
1994-05-11 |
Merck & Co Inc |
Optimized tablet formulation
|
US5198438A
(en)
*
|
1991-05-07 |
1993-03-30 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
US5506361A
(en)
*
|
1991-05-08 |
1996-04-09 |
Theupjohn Company |
Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
|
US5223501A
(en)
*
|
1991-05-10 |
1993-06-29 |
Merck & Co., Inc. |
Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
|
GB9110625D0
(en)
*
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
GB9110636D0
(en)
*
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
US5332820A
(en)
*
|
1991-05-20 |
1994-07-26 |
E. I. Du Pont De Nemours And Company |
Dibenzobicyclo(2.2.2) octane angiotensin II antagonists
|
US5175164A
(en)
*
|
1991-06-05 |
1992-12-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
|
US5210211A
(en)
*
|
1991-06-21 |
1993-05-11 |
Warner-Lambert Company |
4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity
|
FR2677984B1
(fr)
*
|
1991-06-21 |
1994-02-25 |
Elf Sanofi |
Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
IL102183A
(en)
*
|
1991-06-27 |
1999-11-30 |
Takeda Chemical Industries Ltd |
The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
|
US5177097A
(en)
*
|
1991-07-24 |
1993-01-05 |
E. R. Squibb & Sons, Inc. |
Acyl amidine and acyl, guanidine substituted biphenyl derivatives
|
AU644539B2
(en)
*
|
1991-09-10 |
1993-12-09 |
Tanabe Seiyaku Co., Ltd. |
Imidazoindolizine derivatives and process for preparation thereof
|
AU644540B2
(en)
*
|
1991-09-10 |
1993-12-09 |
Tanabe Seiyaku Co., Ltd. |
Imidazopyridine derivatives and process for preparation thereof
|
PT533268E
(pt)
*
|
1991-09-18 |
2002-02-28 |
Glaxo Group Ltd |
Derivados de benzanilida como antagonistas de 5-ht1d
|
PT100905A
(pt)
*
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
AT398202B
(de)
*
|
1991-10-04 |
1994-10-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
US5187159A
(en)
*
|
1991-10-07 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
|
US5149699A
(en)
*
|
1991-10-24 |
1992-09-22 |
American Home Products Corporation |
Substituted pyridopyrimidines useful as antgiotensin II antagonists
|
US5256654A
(en)
*
|
1991-10-24 |
1993-10-26 |
American Home Products Corporation |
Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
|
US5484937A
(en)
*
|
1992-08-04 |
1996-01-16 |
G.D. Searle & Co. |
N-substituted N-(α-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders
|
US5252753A
(en)
*
|
1991-11-01 |
1993-10-12 |
Ortho Pharmaceutical Corporation |
Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof
|
US5389661A
(en)
*
|
1991-12-05 |
1995-02-14 |
Warner-Lambert Company |
Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties
|
US5322950A
(en)
*
|
1991-12-05 |
1994-06-21 |
Warner-Lambert Company |
Imidazole with angiotensin II antagonist properties
|
US5212177A
(en)
*
|
1991-12-16 |
1993-05-18 |
E. R. Squibb & Sons, Inc. |
Indole and benzimidazole-substituted dihydropyrimidine derivatives
|
US5234923A
(en)
*
|
1991-12-16 |
1993-08-10 |
E. R. Squibb & Sons, Inc. |
Substitute indole and benzimidazole derivatives
|
US5350752A
(en)
*
|
1991-12-16 |
1994-09-27 |
E. R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
US5308853A
(en)
*
|
1991-12-20 |
1994-05-03 |
Warner-Lambert Company |
Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
|
EP0550313A1
(fr)
*
|
1991-12-30 |
1993-07-07 |
Synthelabo |
Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
|
FR2685697B1
(fr)
*
|
1991-12-30 |
1994-02-04 |
Synthelabo |
Nouveaux derives de 2-(tetrazol-5-yl)-(1,1'-biphenyle), leur preparation et leur utilisation comme intermediaires de synthese.
|
US5240953A
(en)
*
|
1992-01-30 |
1993-08-31 |
Ortho Pharmaceutical Corporation |
Substituted triazoles as angiotensin ii inhibitors
|
US5312958A
(en)
*
|
1992-01-31 |
1994-05-17 |
Takeda Chemical Industries, Ltd. |
Process for producing 4-bromomethylbiphenyl compounds
|
DE4206043A1
(de)
*
|
1992-02-27 |
1993-09-02 |
Bayer Ag |
Sulfonylbenzyl-substituierte imidazole
|
TW215434B
(xx)
*
|
1992-03-07 |
1993-11-01 |
Hoechst Ag |
|
US5208234A
(en)
*
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Substituted imidazole phosphonic and phosphinic acid derivatives
|
US5208235A
(en)
*
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Indole- and benzimidazole-substituted imidazole derivatives
|
FR2689508B1
(fr)
*
|
1992-04-01 |
1994-06-17 |
Fournier Ind & Sante |
Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.
|
US5972990A
(en)
*
|
1992-04-10 |
1999-10-26 |
Brigham And Women's Hospital, Inc. |
Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
|
US5378704A
(en)
*
|
1992-04-15 |
1995-01-03 |
E. R. Squibb & Sons, Inc. |
Non-peptidic angiotensin-II-receptor-antagonists
|
US5294722A
(en)
*
|
1992-04-16 |
1994-03-15 |
E. R. Squibb & Sons, Inc. |
Process for the preparation of imidazoles useful in angiotensin II antagonism
|
US5218125A
(en)
*
|
1992-04-23 |
1993-06-08 |
Merck & Co., Inc. |
Antihypertensive compound and method of use thereas
|
US5214153A
(en)
*
|
1992-04-23 |
1993-05-25 |
Merck & Co., Inc. |
Actinoplanes transformation process anti-hypertensive compound and method of use thereas
|
US5217882A
(en)
*
|
1992-05-18 |
1993-06-08 |
Merck & Co., Inc. |
Microbial transformation process for producing antihypertensive N2 -glucuronide products
|
DE69329982T2
(de)
*
|
1992-06-02 |
2001-09-27 |
Sankyo Co., Ltd. |
4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung
|
US5401851A
(en)
*
|
1992-06-03 |
1995-03-28 |
Eli Lilly And Company |
Angiotensin II antagonists
|
DE4221009A1
(de)
*
|
1992-06-26 |
1994-01-05 |
Bayer Ag |
Imidazolyl-substituierte Cyclohexanderivate
|
EP0577023A3
(en)
*
|
1992-07-01 |
1996-12-18 |
Hoechst Ag |
Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
|
US5484955A
(en)
*
|
1992-07-06 |
1996-01-16 |
Takeda Chemical Industries, Ltd. |
Tri-higher alkyl tin azide and its use
|
GB9218449D0
(en)
|
1992-08-29 |
1992-10-14 |
Boots Co Plc |
Therapeutic agents
|
IT1255461B
(it)
*
|
1992-07-28 |
1995-11-02 |
Luso Farmaco Inst |
Eteri di imidazoli ad attivita' a ii antagonista
|
US5283241A
(en)
*
|
1992-08-28 |
1994-02-01 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5583130A
(en)
*
|
1992-09-25 |
1996-12-10 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5317017A
(en)
*
|
1992-09-30 |
1994-05-31 |
Merck & Co., Inc. |
N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release
|
DE69332736T2
(de)
*
|
1992-12-07 |
2004-03-25 |
Eisai Co., Ltd. |
Verfahren zur herstellung von imidazopyridinderivaten und zwischenprodukte
|
DE4242459A1
(de)
*
|
1992-12-16 |
1994-06-23 |
Merck Patent Gmbh |
Imidazopyridine
|
NO304429B1
(no)
*
|
1992-12-17 |
1998-12-14 |
Sankyo Co |
Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom
|
DE4302956A1
(de)
*
|
1993-02-03 |
1994-08-04 |
Bayer Ag |
Substituierte Imidazo(4,5-b)pyridine und Benzimidazole
|
US5284841A
(en)
*
|
1993-02-04 |
1994-02-08 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5514811A
(en)
*
|
1993-02-15 |
1996-05-07 |
Shikoku Chemicals Corporation |
Process for synthesizing 4-halo-5-(hydroxymethyl) imidazole compounds
|
DK0614890T3
(da)
*
|
1993-03-12 |
1997-10-13 |
Lonza Ag |
Fremgangsmåde til fremstilling af eventuelt 2-substituerede 5-chlorimidazoler.
|
DE4308788A1
(de)
*
|
1993-03-18 |
1994-09-22 |
Bayer Ag |
Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
|
CA2158737A1
(en)
*
|
1993-04-07 |
1994-10-13 |
Keizo Tanikawa |
Pyrazole derivatives
|
US5451597A
(en)
*
|
1993-05-27 |
1995-09-19 |
G.D. Searle & Co. |
Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists
|
LT3469B
(en)
|
1993-06-02 |
1995-10-25 |
Chem Pharm Forsch Gmbh |
Novel acylales of imidazol-5-carboxylic acid derivatives, process for their preparation and use thereof
|
US5508272A
(en)
|
1993-06-15 |
1996-04-16 |
Bristol-Myers Squibb Company |
Compounds containing a fused bicycle ring and processes therefor
|
AU7006094A
(en)
*
|
1993-06-30 |
1995-01-24 |
Wellcome Foundation Limited, The |
Anti-atherosclerotic diaryl compounds
|
US5610301A
(en)
*
|
1993-07-01 |
1997-03-11 |
American Cyanamid Company |
Process for the regioselective n-alkylation of quinazolinones
|
US5338740A
(en)
*
|
1993-07-13 |
1994-08-16 |
Pfizer Inc. |
Angiotensin II receptor antagonists
|
US5342944A
(en)
*
|
1993-07-19 |
1994-08-30 |
American Cyanamid Company |
Process for the preparation of 2-alkyl-3,5,6,7- or 8-substituted-4(3H)-quinazolinones
|
US5298517A
(en)
*
|
1993-10-07 |
1994-03-29 |
American Cyanamid Company |
Angiotensin II receptor blocking agents
|
US5438136A
(en)
*
|
1993-11-02 |
1995-08-01 |
Merck & Co., Inc. |
Benzo-fused macrocycles promote release of growth hormone
|
US5606054A
(en)
*
|
1993-12-14 |
1997-02-25 |
Merck & Co., Inc. |
Heterocyclic-fused lactams promote release of growth hormone
|
HUT74734A
(en)
*
|
1994-03-16 |
1997-02-28 |
Sankyo Co |
Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
|
US5753672A
(en)
*
|
1994-04-19 |
1998-05-19 |
Tanabe Seiyaku Co., Ltd. |
Imidazopyridine derivatives and process for preparing the same
|
SE9502219D0
(sv)
*
|
1995-06-19 |
1995-06-19 |
Astra Ab |
Novel medical use
|
CZ35998A3
(cs)
*
|
1995-08-10 |
1998-07-15 |
Sumitomo Chemical Company, Limited |
Pyrimidin-4-onové deriváty, jejich použití, meziprodukty pro jejich přípravu a způsob přípravy těchto meziproduktů
|
US6071931A
(en)
*
|
1995-10-06 |
2000-06-06 |
Novartis Ag |
AT1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
|
ATE230263T1
(de)
|
1996-02-29 |
2003-01-15 |
Novartis Erfind Verwalt Gmbh |
At1 rezeptor antagonist zur anregung von apoptosis
|
FR2753195B1
(fr)
|
1996-09-09 |
1998-11-27 |
Sanofi Sa |
Procede pour la preparation d'un cyanobiphenyle
|
JPH10203981A
(ja)
|
1997-01-21 |
1998-08-04 |
Kureha Chem Ind Co Ltd |
心疾患改善剤
|
TW418204B
(en)
*
|
1997-03-28 |
2001-01-11 |
Dev Center Biotechnology |
Novel 1,2,4-triazine-5-ketonyl benzene derivatives and the analogs, the preparation, and the pharmaceutical compositions as angiotension II receptor antogonists
|
EE200000499A
(et)
|
1998-03-04 |
2002-02-15 |
Takeda Chemical Industries, Ltd. |
Angiotensiin II antagonistliku toimega toimeainetprolongeeritult vabastav preparaat, selle valmistamise meetod ja kasutamine
|
DE19820064A1
(de)
*
|
1998-05-06 |
1999-11-11 |
Hoechst Marion Roussel De Gmbh |
Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
|
ATE279396T1
(de)
|
1998-06-12 |
2004-10-15 |
Sod Conseils Rech Applic |
Imidazolderivate und ihre verwendung als somatostatin rezeptorliganden
|
DE19830431A1
(de)
|
1998-07-08 |
2000-01-13 |
Hoechst Marion Roussel De Gmbh |
Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren
|
TR200805275T2
(tr)
|
1998-12-23 |
2008-09-22 |
Novartis Ag |
AT-1 veya AT-2 reseptörlerindeki artışın neden olduğu hastalıkların tedavisi için AT-1 reseptör antagonisti veya AT-2 reseptör modülatörünün kullanımı@
|
US6465502B1
(en)
|
1998-12-23 |
2002-10-15 |
Novartis Ag |
Additional therapeutic use
|
CN101011390A
(zh)
|
1999-01-26 |
2007-08-08 |
诺瓦提斯公司 |
血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
|
SE9903028D0
(sv)
|
1999-08-27 |
1999-08-27 |
Astra Ab |
New use
|
DE60138535D1
(de)
|
2000-02-04 |
2009-06-10 |
Children S Hospital Res Founda |
Verwendung von lysosomal acid lipase zur behandlung von atherosklerose und ähnlichen krankheiten
|
AU2001279098B2
(en)
|
2000-08-01 |
2005-04-14 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S |
Imidazolyl derivatives
|
PE20020617A1
(es)
|
2000-08-22 |
2002-08-05 |
Novartis Ag |
Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
|
US8168616B1
(en)
|
2000-11-17 |
2012-05-01 |
Novartis Ag |
Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
|
BR0102252B1
(pt)
*
|
2001-04-10 |
2013-10-22 |
|
Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
|
WO2003041739A1
(en)
|
2001-11-13 |
2003-05-22 |
Takeda Chemical Industries, Ltd. |
Anticaner agents
|
CA2484897C
(en)
|
2002-05-09 |
2015-10-06 |
The Brigham And Women's Hospital, Inc. |
Soluble st2 as a cardiovascular disease marker and therapeutic target
|
DE60225486T2
(de)
|
2002-06-12 |
2009-04-02 |
Sumitomo Chemical Co., Ltd. |
Verfahren zur herstellung von 4'-brommethyl-2-cyanobiphenyl
|
WO2004011429A1
(ja)
*
|
2002-07-26 |
2004-02-05 |
Nihon Nohyaku Co., Ltd. |
新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法
|
DE10335027A1
(de)
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
DE10306179A1
(de)
|
2003-02-13 |
2004-08-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
GB0316546D0
(en)
|
2003-07-15 |
2003-08-20 |
Novartis Ag |
Process for the manufacture of organic compounds
|
EP1663184A2
(en)
|
2003-08-29 |
2006-06-07 |
The Brigham And Women's Hospital, Inc. |
Hydantoin derivatives as inhibitors of cellular necrosis
|
JP4537678B2
(ja)
*
|
2003-09-04 |
2010-09-01 |
住友化学株式会社 |
2’−(1h−テトラゾール−5−イル)ビフェニル−4−カルボアルデヒド結晶およびその製造方法
|
GB0327839D0
(en)
|
2003-12-01 |
2003-12-31 |
Novartis Ag |
Organic compounds
|
ATE546734T1
(de)
|
2003-12-05 |
2012-03-15 |
Cleveland Clinic Foundation |
Risikomarker für eine herzkreislaufkrankheit
|
GB0402262D0
(en)
|
2004-02-02 |
2004-03-10 |
Novartis Ag |
Process for the manufacture of organic compounds
|
JP2007529459A
(ja)
|
2004-03-17 |
2007-10-25 |
ノバルティス アクチエンゲゼルシャフト |
治療に置けるレニン阻害剤の使用
|
ITTO20040264A1
(it)
*
|
2004-04-28 |
2004-07-28 |
Rotta Res Lab Spa |
Nuovi derivati pirrolici ad attivita' angiotensina-ii antagonista
|
US9164104B2
(en)
|
2004-10-06 |
2015-10-20 |
The Brigham And Women's Hospital, Inc. |
Relevance of achieved levels of markers of systemic inflammation following treatment
|
WO2006038223A1
(en)
*
|
2004-10-06 |
2006-04-13 |
Matrix Laboratories Ltd |
A process for preparation of 2-n-butyl -4-chloro - 1 - {[2`- (2-triphenylmethyl - 2h - tetrazole - 5- yl) - 1, 1’ - biphenyl-4-yl] methyl}-lh- imidazoie-5-methanol (intermediate of losartan)
|
RU2407523C2
(ru)
|
2004-10-08 |
2010-12-27 |
Новартис Аг |
Применение ингибиторов ренина для профилактики или лечения диастолической дисфункции или диастолической сердечной недостаточности
|
WO2006044648A1
(en)
|
2004-10-15 |
2006-04-27 |
Teva Pharmaceutical Industries Ltd. |
Process for preparing telmisartan
|
AU2005297984B2
(en)
|
2004-10-27 |
2009-11-12 |
Daiichi Sankyo Company, Limited |
Benzene compound having 2 or more substituents
|
EP2080756A3
(de)
|
2005-02-03 |
2011-02-16 |
Ratiopharm GmbH |
Verfahren zur Herstellung von Losartan
|
EP2808015A1
(en)
|
2005-05-31 |
2014-12-03 |
Mylan Laboratories, Inc |
Compositions comprising nebivolol
|
EP1752450A1
(en)
|
2005-08-01 |
2007-02-14 |
Merck Sante |
Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
|
KR101050256B1
(ko)
|
2005-08-31 |
2011-07-19 |
수벤 라이프 사이언시스 리미티드 |
로사르탄의 제조 방법
|
US8119358B2
(en)
|
2005-10-11 |
2012-02-21 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
CN101024643A
(zh)
*
|
2006-02-20 |
2007-08-29 |
上海艾力斯医药科技有限公司 |
咪唑-5-羧酸类衍生物、制备方法及其应用
|
CN101085772A
(zh)
*
|
2006-06-07 |
2007-12-12 |
上海艾力斯医药科技有限公司 |
一类具有PPARγ激动剂活性的化合物及其应用
|
US20080057590A1
(en)
|
2006-06-07 |
2008-03-06 |
Mickey Urdea |
Markers associated with arteriovascular events and methods of use thereof
|
EP1908469A1
(en)
|
2006-10-06 |
2008-04-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
|
CA2671816C
(en)
|
2006-12-06 |
2012-06-05 |
Shanghai Allist Pharmaceutical., Inc. |
Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same
|
CN101214242A
(zh)
|
2007-01-05 |
2008-07-09 |
上海艾力斯医药科技有限公司 |
新的药用组合物
|
WO2008104580A1
(en)
|
2007-03-01 |
2008-09-04 |
Probiodrug Ag |
New use of glutaminyl cyclase inhibitors
|
DK2147315T3
(da)
|
2007-04-18 |
2013-09-23 |
Tethys Bioscience Inc |
Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
|
US9656991B2
(en)
|
2007-04-18 |
2017-05-23 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
CN101172953B
(zh)
*
|
2007-12-04 |
2011-12-28 |
王俊华 |
沙坦类治疗高血压药物替米沙坦中间体的制备方法
|
GB2462022B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
|
US8236843B2
(en)
*
|
2008-09-02 |
2012-08-07 |
Elder Pharmaceuticals Ltd. |
Anti inflammatory compounds
|
ES2548913T3
(es)
|
2009-09-11 |
2015-10-21 |
Probiodrug Ag |
Derivados heterocíclicos como inhibidores de glutaminil ciclasa
|
WO2011094730A2
(en)
|
2010-02-01 |
2011-08-04 |
The Hospital For Sick Children |
Remote ischemic conditioning for treatment and reventon of restenosis
|
EP2542549B1
(en)
|
2010-03-03 |
2016-05-11 |
Probiodrug AG |
Inhibitors of glutaminyl cyclase
|
EP2545047B9
(en)
|
2010-03-10 |
2015-06-10 |
Probiodrug AG |
Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
|
CA2795053A1
(en)
|
2010-03-31 |
2011-10-06 |
The Hospital For Sick Children |
Use of remote ischemic conditioning to improve outcome after myocardial infarction
|
EP2555692A2
(en)
|
2010-04-08 |
2013-02-13 |
The Hospital For Sick Children |
Use of remote ischemic conditioning for traumatic injury
|
JP5945532B2
(ja)
|
2010-04-21 |
2016-07-05 |
プロビオドルグ エージー |
グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
|
WO2012123563A1
(en)
|
2011-03-16 |
2012-09-20 |
Probiodrug Ag |
Benz imidazole derivatives as inhibitors of glutaminyl cyclase
|
AU2011365756B2
(en)
|
2011-04-12 |
2015-07-30 |
Boryung Pharmaceutical Co., Ltd. |
Antihypertensive pharmaceutical composition
|
ES2611403T3
(es)
|
2011-07-18 |
2017-05-08 |
Critical Care Diagnostics, Inc. |
Procedimientos de tratamiento de enfermedades cardiovasculares y de predicción de la eficacia de terapia de ejercicio
|
CN103012377A
(zh)
*
|
2011-09-27 |
2013-04-03 |
江苏艾力斯生物医药有限公司 |
一种咪唑-5-羧酸酯的重结晶方法
|
US20130158080A1
(en)
|
2011-12-15 |
2013-06-20 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for treating hypertension in black patients
|
KR20130074808A
(ko)
|
2011-12-16 |
2013-07-05 |
한올바이오파마주식회사 |
스타틴계 지질저하제에 의한 근육계 부작용의 치료 또는 예방을 위한 로사르탄을 포함하는 약제학적 조성물
|
KR102011534B1
(ko)
*
|
2011-12-21 |
2019-08-16 |
오노 야꾸힝 고교 가부시키가이샤 |
인자 XIa 억제제로서 피리디논 및 피리미디논 유도체
|
MX361457B
(es)
|
2012-05-11 |
2018-12-06 |
Reset Therapeutics Inc |
Sulfonamidas que contienen carbazol como moduladoras de criptocromo.
|
CA2881563C
(en)
|
2012-08-01 |
2021-07-20 |
Zahra TAVAKOLI |
Free flowing, frozen compositions comprising a therapeutic agent
|
EP2968276A4
(en)
|
2013-03-15 |
2017-02-15 |
President and Fellows of Harvard College |
Hybrid necroptosis inhibitors
|
TWI690521B
(zh)
|
2014-04-07 |
2020-04-11 |
美商同步製藥公司 |
作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
|
EP3508475A4
(en)
|
2016-08-30 |
2020-04-15 |
Nippon Soda Co., Ltd. |
SULFONYLAMINOBENZAMIDE COMPOUND AND PEST CONTROL
|
EP4299120A3
(en)
|
2017-07-07 |
2024-03-06 |
Boehringer Ingelheim Vetmedica GmbH |
Telmisartan for the prophylaxis or treatment of hypertension in cats
|
DK3461819T3
(da)
|
2017-09-29 |
2020-08-10 |
Probiodrug Ag |
Inhibitorer af glutaminylcyklase
|